Stats

1. Frozen notes651/653, 10ETprice/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-72.392945%, closedwealthDD72.392945%, N664, wins11.144578%, mean-0.193445%, averagewin0.162341%, averageloss0.238069%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, 10ETprice/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-16.249382%, closedwealthDD16.249382%, N93, wins8.602151%, mean-0.190383%, averagewin0.129372%, averageloss0.220477%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, r1positive; earliest signal allowed by maximum3trades/rolling5sessions, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-71.726262%, closedwealthDD71.726262%, N569, wins13.532513%, mean-0.221451%, averagewin0.168343%, averageloss0.282455%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. PDT throttle is perisolatedETF, not a combined account allocation. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, 15:00barclose/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-75.849062%, closedwealthDD75.849062%, N674, wins13.798220%, mean-0.210308%, averagewin0.136409%, averageloss0.265807%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, 10ETprice/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-77.777294%, closedwealthDD77.777294%, N704, wins13.778409%, mean-0.213134%, averagewin0.147373%, averageloss0.270744%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, 15:00barclose/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-73.724632%, closedwealthDD73.724632%, N700, wins12.000000%, mean-0.190217%, averagewin0.283811%, averageloss0.254857%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

1. Frozen notes651/653, 10ETprice/previousdailyclose>1, entry15:30baropen, exitthat30minbarclose; flat same day. Train2016–20, holdout2021–25, recent2026throughSep4. Only full NYSE sessions, calibrated with exchange_calendars4.13.2; adjustedSIPbars https://runway.adityaperswal.workers.dev/data/stock-bars . 2. 5bpfees+5bpslippage EACH side; vectorbt direction=longonly, allavailable strategycapital, cashreconciled independently. Return-75.820904%, closedwealthDD75.820904%, N684, wins11.111111%, mean-0.206817%, averagewin0.271463%, averageloss0.266602%. These are simulated full-capital returns, not account performance. 3. No same-day stop/target or auction-fill guarantee; intrabar drawdown excluded. Conclusion reject this costed transfer, actualsize0. Allsixcostvariants recorded; changingcosts doesnotselectawinner. Originalsources https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf and https://academicweb.nd.edu/~zda/intramom.pdf ; this is an ETF longonly transfer, not full paper replication. The inspected historical marketperiod is not pristine prospective validation.

Start state:49.14Catalystcash,850.99accountequity,zeroopen/queued;goalrepeatablenetpre-eventgain. Bindingconstraint independently validated edge for the actual remainingwindow. NUMBERED PREMISES:1 NewROIVSep6notice placesPHocusERS Sep8 06:15ET before08ETcall and09:30ETopen https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat . No regular-sessionrunup remains.2 FrozenROIVgenericSMA10/50 costedholdout+187.00%,3months-longwins,noobservedlosses andnoeventfilter cannot calibrate a clinicalrunup.3 ExistingCHWYfixed10-sessionholdoutanalysis38 hasN6,p50%,W4.5234%,L4.8287%,return-1.720%,DD14.259%,clippedquarterKelly0; shorteningtoone remainingday is untested. ExistingGISanalysis626holdout+.567%,stress-2.405%,N10/CIcrosses0 also remainsrejected. https://runway.adityaperswal.workers.dev/data/stock-bars ; issuer CHWY https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx .4 LiveCatalystledgerquery_trades readthisrun has0/3wins,meanloss16.3806%,twooperatorliquidations censorstrategyoutcomes; averagewinnerunavailable,nottruep=0.5 NewROIVriskcontext: support/attainabletargetRR1.146;1share30%gap10.4835>8.5099riskbudget; genericfive-sessionbarriermodelnet-1.0207%,notPHocusforecast. CONCLUSION noPROPOSE,EXIT,ADJUST orFUND; adoptedsize/quarterKelly0. Validity: evidencegatesfail,soabstentionfollows; soundness limited by partialIEX,selectedissuer/smallN,no15minutequotes or historicalclinicalfirst-newscohort. Strongcountercase: gooddata couldrally andlongtrendpayoff ispositive; thatdoesnotestablisha current runupentry. Facts end at dates/filings/measuredhistory; success/gaphazard assumptions are unestimated. Who benefits from needless turnover: spreadrecipients; cashpreservescapital. Monthly349.01shortfall isnotmodelinput. Change mind onlywith verifiedevent,unexpiredtestedwindow,independentnetedgeincludinglosses andcosts,executablequotes,realisticRR>=1.5 andgap-awarefund/riskcaps. Favorableresults ->prospectiveresearch; weak/ambiguous/delay ->cash. Calendaranalysis663 andobservations8954–8975 covernext2sessions.20existingmonitorsretained;ROIVadditionrejectedcapacity,collector52replaces33withROIVbranches. NoCatalystmonitorcurrentlydue;do not resolveotherfunds'. Archive20partsnotes660–679 readback20/20,manifest680. No liveholdingneedsstop.

Numpy seed9070800,100000 five-session IID paths sampled from752 ROIV2022–24 daily returns. Unrestricted gross endpoint mean+.46984%,p05-12.52714%,p95+14.86795%,loss49.822%; these are generic daily risk, not clinical outcome forecasts. Descriptive sensitivity uses Sep4ATR1.1575/price34.945 for stop3.312% and target4.969%; daily endpoint checks,stop at actual breached endpoint,target capped,fee5bp/slip10bp eachside. Base netmean-1.02070%,win45.992%,stopfirst44.685%,targetfirst33.972%,time21.343%; one-sharep05-$3.272. Assumed extra30%firstdaygap probabilities1/5/10% produce means-1.29903/-2.49798/-3.96143%; one-share loss>$8.5099 odds.942/4.949/9.894%. Zero added-gap scenario's0exceedances is a finite empirical-model result,not zero real tailrisk. Overlayprobabilities unestimated, IID destroys clustering, dailychecks miss15minute/exthours path, historicalpoolalreadycontainsnews, addedgapmaydoublecount. Positive unconstrained endpoint mean doesnotvalidate a profit-taking strategy. CONCLUSIONsize0; neitherMonteCarlo100000 nor a generic3-winholdout supplies independentclinicaledge or calibratedKelly. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; scriptsroiv.py/simulation.py archived; freezeprospectively ratherthanretunebarriers.

Premises: PHocus randomized135-patient Phase2 primary week16PVR;6MWT andNTproBNPsecondary https://clinicaltrials.gov/api/v2/studies/NCT06635850 . Sponsor once-daily inhaled sGC rationale and separate PHactor combination study with inhaled treprostinil https://www.pulmovant.com/press-release-february-6-2026 . IONS Sep4 outcome provides a counterexample to biomarker-to-clinical extrapolation, not evidence these mechanisms share efficacy https://www.sec.gov/Archives/edgar/data/874015/000114036126035802/ef20081690_8k.htm . FIRST: convincing PVR benefit with acceptable safety could justify further development; null/ambiguous data weakens it. SECOND: sustained functional benefit and tolerability could affect trial recruitment, later prescribing and payer interest; isolated physiology, missing data or subgroup-only effects may not. THIRD: only after approval/access and profitable uptake might competitive or combination economics affect Roivant and incumbent inhaled-treatment franchises; no automatic UTHR short or Roivant buy. Combination development means a rival mechanism need not be pure substitution. Who benefits: patients if outcomes improve, trial providers from further studies; shareholder benefit depends on development cost,ownership and reimbursement. Strongest bull case differentiation plus well-funded development; strongest countercase endpoint or safety gaps and market pricing can absorb good data. Conclusion monitor full data; causal commercial probabilities and margins remain unmeasured,allocation0.

Ran node /app/agent/dist/backtest.js --symbols ROIV --strategy sma-cross --fast 10 --slow 50 --days 1700.1167bars,13closedtrades,+232.8662%,DD50.6925%,win38.4615%,average14.0762%,buyhold336.2672%. Same-close signal/fill, no costs or independent split; source https://runway.adityaperswal.workers.dev/data/stock-bars , /app/agent/dist/backtest.js . This fulfills tooling diagnostic, not event calibration. Separate frozen vectorbt next-open experiment includes chronologicalholdout and fees/slippage. Do not conflate shorter CLI startingdate with the2022-Jan3 vectorbtwindow or choose grossbest result. Verdict not adopted,allocation0.

Preregistered note652 before bars. vectorbt uses previous close's crossover, enters/exits next IEX daily open, fees5bp plus slippage10bp per side; chronological2022–24 train and2025–Sep4 2026 holdout, flat at split, final close liquidation. Baseline10/50: train+10.0652%, maxDD52.0737%,3/11wins,W34.8752%,L8.1652%; holdout+186.9989%,DD12.8047%,3/3wins,W52.4166%,no observed losses. Holdout entries/exits Apr29–Jul14 2025 (+2.1572%),Jul15 2025–May4 2026 (+136.0114%),May13–Sep4 2026 (+19.0810%). These are months-long holdings, not five-session or PHocus runups. Slippage25bp holdout+184.4275%,train+6.4923%. Predeclared adjacent fast5/20: train-33.5916/+48.8584%,holdout+107.5309/+203.3550%,N8/1 respectively; no winning variant selected. Premises: positive selected-issuer generic record, tiny holdout and unobserved loss tail, no clinical calendar filter, no validated stop/target or15minute execution. CONCLUSION reject for Catalyst sizing and no FUND proposal; independent diversified validation is absent. Strong counterargument trend is cost-robust; accept measured return but not inference to event success or fresh entry. This now-inspected holdout cannot be reused to retune. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; research/backtest.py and trade vectors, observations8988–8999. Both return and drawdown are percent; no claim three wins establish p=1.

Source Sep4IEX https://runway.adityaperswal.workers.dev/data/stock-bars ; SMA10/20/50=35.454/35.91775/35.2768. Close34.945 isbelowallthree,20sessionreturn-3.77255%,yetSMA10still>SMA50. A laggingpositivecrossoverstate isnotfreshentrysignal andrecentpriceweakness doesnotprovefailure. FrozenSMA10/50genericbacktestlastentryMay13,notSep7; thereisno mandate-compatiblepre-eventsessionleft. Premises indicatorsmixdifferentlookbacks; conclusionnooptimisticpick-oneinterpretation. Counterargumentlongtrendmayresume; acceptpossibilitywithoutconvertingitintoPHocussuccessprobability. No newsubgroup search orfitonnowseenholdout; allocation0.

Sep4completedIEXbar34.945; simpleATR14=1.1575,ADR14=1.12,20daylow/high33.43/37.92,20dayreturn-3.77255%,annualized20dayvol35.02595%,meanIEXvolume350422.75. Source https://runway.adityaperswal.workers.dev/data/stock-bars ; observations8981/8985/8987. One share costs34.945 beforecosts within49.14fundcap. Illustrative1ATRstop33.7875/1.5ATRtarget36.68125 yieldsnominal1.5RR but notvalidatedfundamentalinvalidations ororders. Stopat20daylow33.43 givesonly1.146RR withsameattainabletarget; do notstretchto37.92. One-share20%gaploss6.989,30%gap10.4835 exceeds8.5099accountbudget; entirefund20%gap9.828 alsoexceeds. Stopnotguarantee,whole-shareextendedhoursstillcannotboundgap. Premises: affordableordinaryrange,unknownbinarytail,no remainingregularsessionbeforeSep8 06:15ETERS https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat . Conclusionnoorderorstoprequested. Positivepricecontext would notrepair missingeventedge. Rangeestimates arepartialvenue,historical,notexecutablequotes.

Preregisterednote652; numpyOLS dailyROIVreturn=a+bSPYreturn,all-adjustedIEXbars2022-Jan3 throughSep4 2026 https://runway.adityaperswal.workers.dev/data/stock-bars . Chronological2022–24train752pairedreturns beta1.09843,correlation.32355,R2.10468,intercept.04914%/day;2025–Sep4 2026holdout420 beta.91825,corr.39021,R2.15226,intercept.21894%/day. ROIVmean/std daily .09205/3.73385% train,.28739/2.46271%holdout. Premises: lowR2 andlargeidiosyncraticdispersion; clinicaleventisticker-specific. Conclusion macroprintsdescribecontext,notPHocuslikelihood orforecastalpha. Intercepts arein-sampledescriptivefitswithin eachpartition,notout-of-sampleforecasts orcausal abnormalreturnestimates. Countercase broaderisk-oncouldmatter; beta near1supports someexposure butonly10–15% varianceexplained. No statisticalsignificanceorregimestabilityclaimed. Survivorselectedsingleissuer,newscontamination,partialIEXandadjustmentrevisionslimitgeneralization. Requireprospectiveeventdata rather thanrepeatedqueriescreatingfalseindependence; allocation0.

Premises: 1 Sep6 issuer fixes Sep8 ERS06:15ET and investorcall08ET: https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat . 2 Sponsor registry https://clinicaltrials.gov/api/v2/studies/NCT06635850 lastupdatedFeb20 has135actualparticipants,randomizedparallel/quadruplemasking,week16PVRprimary,6MWTdistance/NTproBNPsecondaries. Feb6 sponsor https://www.pulmovant.com/press-release-february-6-2026 describedapproximately120; actual count andlaterdate explain difference. EstimatedDecembercompletion is stale relative to Septembernotice; it does not negate presentation, but actualcutoff andcompleteness must be verified. 3 Aug6 10Q https://www.sec.gov/Archives/edgar/data/1635088/000163508826000090/roiv-20260630.htm June30cash/securities3842.082m,quarterCFOoutflow270.504m (+32.35%YoY),SBC83.342m,repurchases206.729m. Burnrate annualized1082.016m; static cash/burn14.20quarters is arithmetic,notforecast. Subsequent July8Genevant771.6mreceipt is separate fromJune30cash; total950mrecipient amount includesArbutus. Pulmovantownership97%basic/90%FD. July31shares722323015 timesSep4IEX34.945 implies25.242bnmixed-dateequityvalue; June30grosscash5.319/share or15.22% ofthatvalue,notparentNAV. 4 BrepocitinibalreadyapprovedAug27 https://investor.roivant.com/news-releases/news-release-details/priovant-announces-fda-approval-lisrayatm-brepocitinib-adults ; earlier10QpendingQ3language is superseded. CONCLUSION prospectivePHocusreviewonly,size0. Attack: strongcash andacutePVRmechanismcouldsupportdevelopment, but neither establishes sustainedfunctionalbenefit orcommercialeconomics. Valid inference distinguishes finance,physiology andpayoff; soundness limited by sponsorreporting,one-quarterburn,minorityinterests andno completevaluation/reimbursementmodel. Facts end atfilings/design; successprobabilitynotestimated.

1. NYSE https://www.nyse.com/trade/hours-calendars confirms September7 closure; nexttwo stock sessions September8/9. No quant positions, pending orders or due monitors; held-R/target/horizon review is inapplicable. Other-fund due monitors are not quant positions or delegated tasks. 2. Issuer observations8934–8942 confirm INBX Sep8 08ET clinical call; BRZE/CASY Sep8 after-close earnings, GME date-only fullresults followingpreannouncement; CHWY/ASO Sep9 before-open earnings; TYRA/IRD Sep9 08ET clinicalcalls, Inditex Sep9 date-only. Call times are not earliest-release times. Existing monitors46/47/48 and clinicaljob35 remain armed; issuer scans are not execution. 3. Macro8930–8933: Sep8 CensusQFR10ET, NYFedSCE11ET,Fedcredit15ET; Sep9 ECEC/QSS10ET. Added quantmonitors59/60. PPI/CPI Sep10/11, not nexttwo sessions. 4. FDA search found policy/townhall meetings, not a newly confirmed Sep8/9 PDUFA; bounded negative finding, not exhaustive absence. TLX deadlineSep11, earlydecisionpossible. Conclusion pre-open orders/stops none while edge unvalidated. Favorable events: record complete prospective evidence and test independent net payoff; adverse/ambiguous: record equally and staycash. Mind changes only with positive training/holdout/coststress, uncertainty abovezero, executable actualmanagement, freshsignal and sizing within212.7475position/8.5099nominalrisk/245.69fundcash. Mere news,gap or monthlyshortfall cannot satisfy those gates. PrimaryURLs are individually recorded in observations8930–8944.

1. Exact fill returns are -5.392364%,+7.939941%,-5.130499%; p=33.333%,averagewin7.939941%,averageloss5.261432%,mean-0.860974%,realized-$1.046053. Wilson95% win interval[6.149,79.234]% makes precision low. 2. All three exits were operator liquidations, not the planned4–6week stop/target or a common rule; stop-hit and target-hit probabilities are unmeasured. All entry orders were market, with no contemporaneous reference quotes, so slippage-by-session comparisons cannot be identified. Conclusion raw quarterKelly0 and actualsize0; do not transfer these returns to intraday momentum or claim a PEAD win probability. The strongest counterargument is DELL's7.94% gain, but one selected winner cannot identify the intended payoff. Source firstparty query_trades(fund=quant) September7; exact arithmetic saved research/ledger.json.

1. August31 issuer preliminary sales780–800m and operatingincome150–170m imply midpoint revenue decline18.741% yet operatingmargin20.253% versus6.830% prior-year; changing scope/store closures complicate organic comparisons. 2. Net eBay/digital investment gains163m equal54.333% of midpoint netincome300m; do not annualize that as repeatable retail earnings or subtract it as tax-adjusted EPS. 3. Cash/securities midpoint5060m is down41.799%, with conversion to4947m eBay stake explaining part of the asset mix, not necessarily operating burn. Conclusion September8 complete results must be compared with already-published August31 ranges and cashflow/reconciliation. A higher EPS headline alone is not a fresh surprise or numerical PEAD edge. Strongest counterargument: operatingmargin improvement could be durable; full filings, comparable scopes and cash conversion could strengthen that premise but still require independent net drift validation. Fair equity value cannot be inferred without debt/dilution and contemporaneous prices; no valuation target or trade. Source https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx . Existing catalyst monitor15 covers followup; quant does not duplicate an order.

Primary date observations8954–8975 contain individual source URLs and claim dates. Premises: 1 NYSE https://www.nyse.com/trade/hours-calendars closesSep7; next regularopenSep8 09:30ET. 2 ROIV Sep8 ERS06:15ET precedes08ETcall (https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat); INBX08ETcall, ABM/UNFI morning also precedeopen. No regular-session entry/exit window remains for these. 3 Sep8afterclose BRZE/CASY/AVO and date-onlyGME, Sep9beforeopenCHWY/ASO, Sep9TYRA/IRD08ETcalls and ITX.MCdate-only provide at most one remaining US session; none inherits a tested multi-session run-up. 4 GMEpreannouncedAug31; confirmation is not unanticipated information. CONCLUSION retain research-only calendar and zero pre-open orders. Strong counterargument: extended-hour runups or one-session trades could work, but no own costed evidence estimates that edge and earliest news is uncertain. Inference valid under mandate's evidence requirement; soundness limited by selected universe and incomplete FDA dynamically populatedcalendar, not proof no other events exist. Macro: Sep8 CensusQFR10ET,NYFedSCE11ET,Fedcredit15ET; Sep9 BLSJuneECEC/CensusQ2QSS10ET,EIASTEOdate-only. PPI/CPI and holiday-delayed petroleum are Sep10/11, not Sep8/9. https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.newyorkfed.org/research/calendars/i-sep26.html ; https://www.federalreserve.gov/newsevents/2026-september.htm ; https://www.bls.gov/schedule/2026/09_sched.htm ; https://www.eia.gov/outlooks/steo/outlook.php ; https://www.eia.gov/petroleum/supply/weekly/schedule.php . No Catalyst monitor due. Other funds' due monitors are outside thisbook; do not resolve them. Explicit freshaccess gap CASY PDF403, issuerindex corroborates prior date. Positive operational/clinical evidence changes watch status only; entry also needs new independent net validation, executable quotes and pre-event exit.

Start state: crypto all cash$235.86, total equity$850.99, no open or pending crypto orders in rereadledger. Goal: positive repeatable returns before the next session; binding constraint is a credible independent net edge, not available cash. Premises:1 analysis649 finds recipient still3998.49878021BTC and stale/divergent Liquid explorers; custody restoration unverified.2 analysis655 checks30daily/728hourlybars per7nonstablecoin names, currentdata mostly internallyconsistent but older provenance and executabledepth unresolved.3 analysis659 recomputes frozenhourly net expectancyBTC-.6329%,ETH-.7069%,SOL-.5734% pertrade, clippedquarterKelly0; daily alternativesN0/2/1 cannot override.4 analysis658 verifies nexttwoUSsessions: Sep8QFR14UTC,SCE15UTC,consumercredit19UTC;Sep9compensation/services14UTC. ETFsharebaselinesstillSep4, SepoliaOct6testnet. Conclusion noPROPOSE/EXIT/ADJUST/FUND, retaincash. Soundness: notproof allfuturecryptoedgesfail; only currentvalidationgatesfail. Strongestcounterexample momentum inLINKcouldcontinue orbridgecouldrecover beforeindexedconfirmation; neither supplies independently calibratedpayoff. $8.5099equityrisk and$212.7475positionceilings arehardmaxima, nottargets; no defendable nonzero sizing orstop/targetorder exists whileKelly0. Who benefitsfromunnecessaryturnover:venuefees/marketmakers; turnovercosts reducecapital thenrunway. Positive macro/flow evidence changesresearchpriority only; tradingchangerequires untouchedcosted daily/hourlyvalidation and15minuteexecutionstress. Monitor55completed,57rearmed12:30;44/45retained. Collector49dualexplorer/custody19x15min,50quotes10x30min,51funding5x60min accepted aftercancel45/46;47exhausted;14/25retained. Allthree scripts locallypassed; firstscheduledexecutions stillunverified at08:06, nextmanagercheck. Analysis/observations/lessons recorded, finish within~8min of36planned/hard45, nooverrun; finalphase reserved since~08:06. Gaps explicitlyin note656: operatorX403,malformedRSS,olderbarprovenance,actual15minfills,globalstablecoinsupply/exchangeflow coverage. Sources https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://blockstream.info/api/address/bc1ql4mfu6aundtkksxklfajs2h3t9nzcd6gyqjlte ; https://blockstream.info/liquid/api/blocks ; https://liquid.network/api/blocks ; https://docs.alpaca.markets/us/docs/crypto-fees ; publishingagency andissuerURLs in658.

1. Retain supply cash $278.67, proposed $0. Live ledger has two closed operator liquidations, zero open/pending. Own mean win2.27871%, no loss sample; quarter-Kelly undefined. FRO frozen N41 mean interval[-0.874362,1.958541]% and negative AA/CENX actual-exit holdouts do not qualify. Prior CLI/vectorbt/indicator/simulation work retained, no new backtest claimed. Source https://runway.adityaperswal.workers.dev/data/stock-bars . New analyses651/652/656/657 record statistics, fundamentals, consequences and technical gate. 2. Sep8: Census Q2QFR10ET https://www.census.gov/economic-indicators/calendar-listview.html ; ASPI10–12:30ET https://ir.aspisotopes.com/news-events/press-releases/detail/112/asp-isotopes-to-hold-capital-markets-day-on-september-8 ; NYFedSCE11ET https://www.newyorkfed.org/research/calendars/i-sep26.html ; FedConsumerCredit15ET https://www.federalreserve.gov/newsevents/2026-september.htm . BRZEafterclose/call16:30ET and GMEexpectedcompleteQ2 dateonly verified in observations8923/8924 with issuerURLs. CASYafterclose retained from prior461/contextmonitor18; PDFrefreshfailed, not newly verified. 3. Sep9: CHWYbeforeopen/call08ET, ASObeforeopen/call10ET, Inditexhalfyeardateonly: primaryURLs observations8921/8922/8925. June ECEC10ET https://www.bls.gov/schedule/2026/09_sched.htm ; Q2services10ET Censusabove; monthlySTEOdateonly https://www.eia.gov/outlooks/steo/outlook.php . WeeklyoilSep10noonET https://www.eia.gov/petroleum/supply/weekly/schedule.php ; PPI/CPIoutsidewindow. No verified supply-relevantSep8/9FDAdecision found, not comprehensiveabsence https://www.fda.gov/advisory-committees . Otherfundclinicalwebcasts are not FDAdecisions. 4. New monitor58 QFR Sep8 12:30ET review after10ETrelease, bothbranches researchonly. Inspect2026Q2disclosurechange and same-vintage comparisons; home/PDF DAOidentifier discrepancy unresolved. Sources https://www.census.gov/econ/qfr/index.html and https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf . Existing43ASPI/49STEO/50weeklyoil retained. No supplymonitor due now or before nextSep7 12:30UTC holidayreview; otherfunddue6/55 not ours. Closure https://www.nyse.com/trade/hours-calendars . 5. Change-mind gates: accepted profitable ASPIshipments/newfirmofftake or demonstrated carrier incrementalnetcash -> recordprospectively and require independentcostedstockedge. Delays,dilution,lower shippedvolume orrestoration -> weaken scarcitythesis. QFRcan corroborate Q2margins,not Septemberweather. Neither branch automatically authorizestrade. Futurequalifyingorder needs freshwhole-sharequote,realistic>=1.5R,nominalrisk<=8.5099,position<=212.7475,fund<=278.67 and+1Rgainplan. No defensibleorderlevels now. 6. Fivejobs12/18/36/39/44 retained. Job39nextSep7 10:00:56UTC before nextrun; local08:03fourHTTP200 hashesmatch06UTC. Helium36next12:45after nextreview; old5success/3failedpanels remain gap. No duplicatejob. No eligiblepremisechanged. Gaps: actualnetbacks/valuation,15minexitdepth, GSCPIrenderedvalue,CASYrefresh andforeignsubsidiarycoverage; observation8946 retracts unsupported overseasplantclaim. Conclusions valid conditional on edge gate; soundness remains limited by these gaps. Scarcity may reprice before cash, but that counterexample does not calibrate payoff. 7. Approximately7minutes used; no thread overran. Finish records/lessons239–241 completed. Initial finalstrategy write exceeded4000characters and was rejected; this compact replacement is the actual saved decision. No trading tools used.

1. GHLZ defines a last-half-hour timing rule with a same-day exit; https://smallake.kr/wp-content/uploads/2015/01/SSRN-id2440866.pdf . 2. Robeco-affiliated authors study rest-of-day momentum in a broader futures universe and explicitly warn that their main results exclude costs; https://academicweb.nd.edu/~zda/intramom.pdf . 3. Our cash account permits long exposure only and has three day trades per rolling five sessions, no guaranteed closing-auction execution or automated scheduled time exit. Conclusion: test long-only ETF transfers under frozen notes651/653 and reject before adding management if net economics fail. Original rule is distinct from failed ATR-template experiments. Actual order size stays0 while results or actual stop/target/time-exit implementation remain unvalidated. Four ETFs are deliberately selected survivors, not an unbiased global universe; historical holdout2021–25 is unseen under this rule but the market period has already been examined by the fund. Current dealer gamma and exact costs unknown. No optimization on inspected holdout. Start245.69cash; goal replicable net edge; binding constraint tradable payoff, not monthly shortfall.

Premises:1 frozen calendar/aggregation sensitivity backtests596/597/598 (06UTC) supply BTC p=29/115,w=.9911125444%,l=1.180520989%; ETH p=12/118,w=4.177281755%,l=1.259869640%; SOL p=12/107,w=5.200698903%,l=1.302715925%. 2 Python recomputation E=p*w-(1-p)*l gives -.63289/-.70694/-.57336% per completed trade; quarter Kelly .25*(p-(1-p)/(w/l)) gives negative estimates, therefore zero eligible allocation. Costed holdout returns-52.1851/-58.5744/-49.2381%,drawdowns52.2339/66.9159/60.9755%,winrates25.2174/10.1695/11.2150%. These are archived experiments reviewed now, not rerun or new independent evidence. 3 Own ledger trade10 is one BTC operator liquidation after47.93min with-.08099%price return; intended3-4week strategy censored, no wins or full strategy exits, fee/slippage attribution unavailable. Conclusion no reliable positive realized or tested edge to size. Strong counterargument daily alternatives have positive1-2trade sensitivity results; no meaningful loss population and hourlyfailure prevent adopting them. Prior simulation605/606 showed drift-removed doubled-cost means approximately-1.2%; alreadyinspected simulations are scenarios, notindependent edge. Soundness limited by olderbarprovenance and sparse daily samples, so no universalclaim all crypto rulesfail. No retuning ornewCLItest in this refresh because rule state stays rejected; prior CLI and vectorbt experiments retained rather than doublecounted. Sources internalresearch596-598,605-606; https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://docs.alpaca.markets/us/docs/crypto-fees ; query_trades fundcrypto.

Premises: 1. On September7 the issuer pages still date IBIT's1,384,960,000 and ETHA's464,560,000 shares to September4. Those unchanged dated records do not establish zero flow since then; no newer measurement exists here. 2. Publishing agencies confirm September8 Census Q2 financial reports10ET, NYFed consumer expectations11ET, Fed consumer credit15ET; September9 BLS June employer compensation and Census Q2 services10ET. PPI/CPI September10/11 fall outside these two sessions. 3. September3 Ethereum developer decision places Sepolia onOctober6, not September9; mainnet timing unverified. Conclusion: calendar sets research checkpoints, not expected returns. Counterexample: an unanticipated macro surprise can move crypto sharply; without a calibrated conditional price model its direction/magnitude cannot justify an order. First transmission assumption: inflation/credit news can change rates/liquidity expectations; next leveraged positioning responds; then spot demand may shift. No quantified causal coefficient adopted. Existing monitors44/45 retained, next-run12:30UTC review57 added. Earnings/FDA company-specific events lie outside this crypto edge unless a documented transmission emerges; no such trade proposed. Sources https://www.newyorkfed.org/research/calendars/i-sep26.html ; https://www.federalreserve.gov/newsevents/2026-september.htm ; https://www.bls.gov/schedule/2026/ ; https://www.census.gov/economic-indicators/calendar-listview.html ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf ; https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf ; https://ethereum-magicians.org/t/all-core-devs-consensus-acdc-186-september-3-2026/29496 .